Analyst Reco. RXO, Inc.

Equities

RXO

US74982T1034

Ground Freight & Logistics

Market Closed - Nyse Other stock markets 21:00:02 05/06/2026 BST			5-day change	1st Jan Change
26.86 ^USD	-2.79%		+5.00%	+112.50%

05-19	RXO Expects May Truckload Gross Profit Per Load to Exceed Typical Seasonality	MT
05-19	Rxo provides brokerage update, including improved outlook for truckload gross profit per load	RE

Analyst Reco.

05-15	RXO Shares Rise After Stifel Upgrade	MT
05-15	Stifel Upgrades RXO to Buy From Hold, Price Target is $22	MT
05-08	UBS Raises RXO Price Target to $22 From $17, Maintains Neutral Rating	MT
05-08	Morgan Stanley Downgrades RXO to Equalweight From Overweight, Lifts Price Target to $22 From $19	MT
11-11	Morgan Stanley Upgrades RXO to Overweight From Equalweight	MT
11-07	UBS Adjusts Price Target on RXO to $15 From $17, Maintains Neutral Rating	MT
03/10/25	UBS Adjusts RXO Price Target to $17 From $15, Maintains Neutral Rating	MT
08/08/25	UBS Lifts Price Target on RXO to $15 From $14, Maintains Neutral Rating	MT
07/07/25	Morgan Stanley Lowers Price Target on RXO to $21 From $23, Keeps Equalweight Rating	MT
16/05/25	BofA Securities Adjusts RXO Price Target to $18 From $15, Maintains Neutral Rating	MT
08/05/25	UBS Cuts Price Target on RXO to $14 From $24, Keeps Neutral Rating	MT
04/04/25	Oppenheimer Downgrades RXO to Market Perform From Outperform	MT
13/03/25	Truist Securities Initiates Coverage on RXO With Buy Rating, $24 Price Target	MT
07/03/25	Deutsche Bank Initiates RXO With Hold Rating, $19 Price Target	MT
12/11/24	Citigroup Downgrades RXO to Neutral From Buy, Price Target is $33	MT
14/10/24	BofA Adjusts Price Target on RXO to $31 From $30, Maintains Neutral Rating	MT
09/10/24	Citigroup Initiates RXO at Buy With $33 Price Target	MT
08/08/24	UBS Adjusts RXO Price Target to $31 From $22, Maintains Neutral Rating	MT
08/08/24	Oppenheimer Adjusts RXO Price Target to $31 From $22, Maintains Outperform Rating	MT
22/07/24	BofA Securities Adjusts Price Target on RXO to $32 From $22, Maintains Neutral Rating	MT
16/07/24	Barclays Raises Price Target on RXO to $30 From $24, Maintains Overweight Rating	MT
09/07/24	JPMorgan Adjusts Price Target on RXO to $25 From $16, Maintains Underweight Rating	MT
25/03/24	Susquehanna Raises RXO Price Target to $16 From $15, Maintains Negative Rating	MT
13/02/24	Oppenheimer Trims RXO Price Target to $22 From $23, Maintains Outperform Rating	MT
09/02/24	UBS Adjusts RXO Price Target to $22 From $20, Maintains Neutral Rating	MT